Genetics & Genomics

Management of Individuals With a Mutation in the Ataxia Telangiectasia Mutated Gene

genetics, genetic testing, hereditary cancer syndromes, breast cancer, colon cancer, ataxia telangiectasia
ONF 2016, 43(1), 114-117. DOI: 10.1188/16.ONF.114-117

Advances in genetic testing have led to the identification of multiple genes associated with a hereditary risk for developing breast and other cancers. One such gene is the ataxia telangiectasia mutated (ATM) gene, which is available on many genetic panels offered to individuals with suspected hereditary risk. Genetic testing can often lead to improved understanding and clarification of risk for developing cancer, as well as allow affected individuals to make informed choices about management, including the adoption of primary prevention strategies and more aggressive screening than typically recommended in the general population. This article provides an overview of the role of mutations in the ATM gene in developing malignancies, along with emerging research on treatment implications based on genetic testing results.

Members Only
Not a current ONS member or journal subscriber?

Purchase This Article

Receive a PDF to download and print.